Substance / Medication

Deferoxamine

Overview

Active Ingredient
deferoxamine
RxNorm CUI
3131

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The role of the iron-chelating agent deferoxamine in spinal cord injury: a systematic review and meta-analysis of preclinical studies.
Moradi Mehrnaz, Najibi Amirhossein, Moshfeghinia Reza et al. · Spine J · 2026
PMID: 40653020Meta-Analysis
Deferoxamine in intracerebral hemorrhage: Systematic review and meta-analysis.
Sun Tao, Zhao Yang-Yang, Xiao Qiu-Xiang et al. · Clin Neurol Neurosurg · 2023
PMID: 36857886Meta-Analysis
Deferoxamine therapy for intracerebral hemorrhage: A systematic review.
Zeng Liling, Tan Li, Li Haijun et al. · PLoS One · 2018
PMID: 29566000Meta-AnalysisFull text (PMC)
Efficacy and safety of deferoxamine in moderately ill COVID-19 patients: An open label, randomized controlled trial.
Ameri Ali, Pourseyedi Farnaz, Davoodian Parivash et al. · Medicine (Baltimore) · 2024
PMID: 39183421RCTFull text (PMC)
A 1-year randomized trial of deferasirox alone versus deferasirox and deferoxamine combination for the treatment of iron overload in thalassemia major.
Eghbali Aziz, Shokri Pooria, Afzal Roghayeh Rahimi et al. · Transfus Apher Sci · 2019
PMID: 31229401RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Deferoxamine (substance)
SNOMED CT
372825006
UMLS CUI
C0011145
RxNorm CUI
3131

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.